Navigation Links
For Moderate to Severe Psoriasis, Thought Leaders' Opinions and Clinical Data Indicate That Emerging Biologics That Target IL-17 Have the Potential to Offer Improvements in Efficacy and Safety Over Current Therapies
Date:6/24/2013

s with improvements in efficacy. However, for drugs that are priced at a premium to adalimumab, MCO pharmacy directors indicate that improvements in the risk of serious infections will need to be substantial to secure reimbursement.

"When asked about factors influencing their treatment decisions, surveyed U.S. and European dermatologists assigned a high weight to a therapy's effect on psoriatic plaques at 12-16 weeks. However, they did not identify this attribute as an area of high unmet need," said Decision Resources Analyst Laura Croal, Ph.D. "The current market contains several biologic therapies with high levels of plaque clearance at 12-16 weeks. Greater unmet need was indicated for improvements on serious infection rates and sustained response rates beyond one year. Drug developers who invest in pivotal trials that extend to 52 weeks and then follow patients through several years of treatment may be in a position to fulfill these remaining unmet needs and differentiate their therapies in this increasingly crowded market."

About Decision Resources
Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective h
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma
2. Nektar Announces that FDA Grants Fast Track Designation to NKTR-181, a New Oral Opioid Analgesic Molecule, for the Treatment of Moderate to Severe Chronic Pain
3. Johnson & Johnson Announces Discontinuation of Phase 3 Development of Bapineuzumab Intravenous (IV) in Mild-to-Moderate Alzheimers Disease
4. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
5. AG Mednet CEO Abraham Gutman to Moderate Disruptive Technologies Session at CenterWatch Forum on Optimizing Clinical Research Performance
6. Rheumatoid Arthritis Patients are Moderately to Highly Satisfied with Their Current Drug Therapy, Rating Conventional DMARDs Highest on Ease of Use and Cost
7. Five-Year SIMPONI Data Reported In Treatment Of Signs And Symptoms Of Moderately To Severely Active Rheumatoid Arthritis
8. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
9. New data about the safety and efficacy of linagliptin in adults with type 2 diabetes who have moderate to severe renal impairment presented at ADA
10. Albireo Receives Positive Opinion for Orphan Drug Designation for A4250 for Severe Liver Diseases
11. Lilly Supports Research to Determine What a Dogs Nose Knows About People with Diabetes and Severe Hypoglycemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Product Segments: SPECT Systems (Includes SPECT and SPECT/CT systems), and ... separate comprehensive analytics for the US, Canada ... , Asia-Pacific , Latin America ... are provided for the period 2013 through 2020. Also, a ...
(Date:9/16/2014)... 2014 This report analyzes the worldwide markets for ... Parasiticides, Vaccines, Anti-Infectives, Medicinal Feed Additives, and Others. The report ... Animals. The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , ... Annual estimates and forecasts are provided for the period 2013 ...
(Date:9/16/2014)... , Sept. 16, 2014  ROX Medical ... an international multi-center, prospective, randomized, controlled, blinded endpoint ... of arterial hypertension. The CONTROL-HTN trial, NCT01642498, evaluated the ... a fixed connection between a central artery and ... treatment of hypertension. The primary outcomes are reduction ...
Breaking Medicine Technology:Global Nuclear Medicine Imaging Equipment Industry 2Global Nuclear Medicine Imaging Equipment Industry 3Global Nuclear Medicine Imaging Equipment Industry 4Global Nuclear Medicine Imaging Equipment Industry 5Global Nuclear Medicine Imaging Equipment Industry 6Global Nuclear Medicine Imaging Equipment Industry 7Global Nuclear Medicine Imaging Equipment Industry 8Global Nuclear Medicine Imaging Equipment Industry 9Global Nuclear Medicine Imaging Equipment Industry 10Global Nuclear Medicine Imaging Equipment Industry 11Global Nuclear Medicine Imaging Equipment Industry 12Global Nuclear Medicine Imaging Equipment Industry 13Global Nuclear Medicine Imaging Equipment Industry 14Global Nuclear Medicine Imaging Equipment Industry 15Global Nuclear Medicine Imaging Equipment Industry 16Global Nuclear Medicine Imaging Equipment Industry 17Global Nuclear Medicine Imaging Equipment Industry 18Global Nuclear Medicine Imaging Equipment Industry 19Global Nuclear Medicine Imaging Equipment Industry 20Global Nuclear Medicine Imaging Equipment Industry 21Global Nuclear Medicine Imaging Equipment Industry 22Global Nuclear Medicine Imaging Equipment Industry 23Global Nuclear Medicine Imaging Equipment Industry 24Global Nuclear Medicine Imaging Equipment Industry 25Global Nuclear Medicine Imaging Equipment Industry 26Global Animal Medication Industry 2Global Animal Medication Industry 3Global Animal Medication Industry 4Global Animal Medication Industry 5Global Animal Medication Industry 6Global Animal Medication Industry 7Global Animal Medication Industry 8Global Animal Medication Industry 9Global Animal Medication Industry 10Global Animal Medication Industry 11
(Date:9/16/2014)... Pulmonary Hypertension Association Travels to San Diego for PHA ... and Families to Help Fight Rare Lung Disease , Who:, ... hypertension association that works to find ways to prevent and ... that affects the functioning of the heart and can lead ... 2.8 years. , What:, PHA On The Road ...
(Date:9/16/2014)... Doheny HealthDay Reporter TUESDAY, ... can routinely spot human papillomavirus (HPV), which is linked to ... "Our study shows that testing urine for HPV has good ... for HPV," said lead researcher Dr. Neha Pathak. She is ... Queen Mary University of London, England. The test could ...
(Date:9/16/2014)... Cliff Lake Dental Care is proud to announce ... dental hygienist to join Dr. Rauchwarter's team. The team at ... and knows she will bring many benefits to the office ... in River Falls, WI. She finished dental assisting school ... practiced dental assisting in the Twin Cities, Milwaukee, California and ...
(Date:9/16/2014)... 2014 Aspen Advisors, a U.S.-based healthcare ... recognized for its high morale and collaborative culture ... Small Firms to Work For 2014.” Consulting magazine ... than 10,000 consultants participating across all major industries, representing ... were conducted, and firms were ranked in six categories ...
(Date:9/16/2014)... Treatment with endocrine therapy and radiation therapy as ... of care for women with hormone-receptor positive (HR+) ... at Fox Chase Cancer Center, however, shows that ... populations with the disease. , The results, ... Society for Radiation Oncology,s 56th Annual Meeting on ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Travels to San Diego for PHA On The Road to Help Fight Rare Lung Disease 3Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 3Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3
... HARBIN, China, Aug. 11 /PRNewswire-Asia-FirstCall/ -- China Sky One,Medical, ... CSKI ), a,leading fully integrated pharmaceutical company ... today announced the launch of,its new corporate website under ... The new website features an expanded ...
... 11 An insidious illness is stealing the vitality of ... closely mirror those of other conditions, it is frequently misdiagnosed, ... know they could prevent the condition, known as systemic Candida, ... Now Kathleen Kalaf, founder and president of the non-profit ...
... localized disease, research shows , TUESDAY, Aug. 11 ... in advanced prostate cancer patients but doesn,t reduce the ... researchers say. , They reported on the long-term survival ... trials launched in 1994. The trials examined the effects ...
... ... a two year partnership with XtremeSportsID™. The NBCF edition of the interactive emergency identification ... fulfill the NBCF mission to save lives through early detection and awareness. , ... Lahaina, HI (PRWEB) August ...
... , BALTIMORE, Aug. 11 , , To ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090811/NY59748LOGO ) , , News Facts ... created an engaging, first-of-its-kind Web-based series called the L e ... journalist Carol Martin . The resource brings together medical doctors, nurses, psychologists, ...
... , RESEARCH TRIANGLE PARK, N.C., Aug. 11 ... today announced the completion of a $16.1 million Series E ... Alta Partners, Sanderling Ventures and Asset Management Company participated in ... Proceeds from the financing will primarily be used to expand ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Launches New Corporate Website 2Health News:China Sky One Medical, Inc. Launches New Corporate Website 3Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 2Health News:Kathleen Kalaf's Atlantic Journey to Wellness Raises Awareness of Systemic Candida and Gains Sponsorship of Renowned Photographer Peter Simon 3Health News:Oral Drug Ups Survival in Advanced Prostate Cancer Cases 2Health News:National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet 2Health News:National Breast Cancer Foundation, Inc to Partner with XtremeSportsID™ on Revolutionary Medical Identification Bracelet 3Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 2Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 3Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 4Health News:Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain 5Health News:Chimerix Raises $16.1 Million in Series E Financing 2
... Reticulocyte Stain is an aqueous ... use in manual methods of ... has a one year shelf ... and can be used in ...
... Liquichek ToRCH Plus IgM Controls ... problems in your ToRCH IgM ... your test results. Liquichek ToRCH ... perfect complement to Liquichek ToRCH ...
... Plus Control is a bilevel ... the performance of the most ... assays. A weak positive and ... to monitor the performance of ...
Liquichek Unassayed Chemistry Control (Human) is a comprehensive, stable, liquid product designed to monitor general and special chemistry tests....
Medicine Products: